Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04116619 · ClinicalTrials.gov registry record

Investigating Stress-related Mechanisms in the Laboratory and Real World in Individuals With Cannabis Use Disorder

A clinical trial, sponsored by Yale University.

Completed
Registry status
39
Enrollment target

NCT04116619 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 39 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04116619 has completed, sponsored by Yale University.

COMPLETED
Registry status
39 participants
Enrollment target

Study Summary

This research project proposes a novel approach to elucidate the biological adaptations associated with Cannabis Use Disorder and to assess whether such adaptations are predictive of higher drug craving in response to both drug cues and stressors in both the laboratory and real-world, and higher relapse risk and drug use in the real world.

Interventions

  • OTHER Guided Imagery Laboratory Session

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2021-02-01
Est. Completion 2022-02-01

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT04116619

The ClinicalTrials.gov registry entry for NCT04116619 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Guided Imagery Laboratory Session is the first listed.

NCT04116619 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04116619 about?

NCT04116619 is a clinical study titled "Investigating Stress-related Mechanisms in the Laboratory and Real World in Individuals With Cannabis Use Disorder". This research project proposes a novel approach to elucidate the biological adaptations associated with Cannabis Use Disorder and to assess whether such adaptations are predictive of higher drug craving in response to both drug cues and stressors in both the laboratory and real-world, and higher rel...

What is the current status of trial NCT04116619?

This trial is currently completed. The enrollment target is 39 participants. The study started on 2021-02-01. Estimated completion is 2022-02-01.

What interventions are being tested in trial NCT04116619?

The interventions under investigation include: Guided Imagery Laboratory Session (OTHER).

Who is sponsoring clinical trial NCT04116619?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.